GAB2 and melanoma: We found that 56% had PAK1 high amplification and 52% had GAB2 high amplification among CCND1 high amplification melanoma patients Figure S1, indicating that co-amplified PAK1 and GAB2 should also participated the worse outcome of melanoma.